Clincosm LogoSign in Get a demo

Hematology Biobank : Invitro Study of Blood Disorders

Sponsor
Albert Einstein College of Medicine (Other)
Overall Status
Recruiting
CT.gov ID
NCT02442011
Collaborator
(none)
1,000
Enrollment
1
Location
143
Duration (Months)
7
Patients Per Site Per Month

Study Details

Study Description

Brief Summary

This is a bio repository of blood specimens from subjects with different Hematological disorders.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    There has been a marked increase in our knowledge of Blood Disorders in the last decade. Much of this knowledge comes from examining blood specimens from patients and subjecting these samples to red cell, plasma, serum or DNA analyses. We propose to set up a Hematology biobank, which will include patient histories, their medical progress and a linked but de-identified bank of blood samples. This will enable us to have a large database, which can be used to learn more about these diseases.

    The Hematology biobank will use whole blood, red blood cells, plasma, serum and/or DNA.

    Study Design

    Study Type:
    Observational
    Anticipated Enrollment :
    1000 participants
    Observational Model:
    Case-Only
    Time Perspective:
    Prospective
    Official Title:
    Hematology Biobank : Invitro Study of Blood Disorders
    Study Start Date :
    Jan 1, 2014
    Anticipated Primary Completion Date :
    Dec 1, 2025
    Anticipated Study Completion Date :
    Dec 1, 2025

    Outcome Measures

    Primary Outcome Measures

    1. Biobank [5 years]

      To have specimens available for IRB approved studies

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:

    Above 18 years of age and able to consent

    Exclusion Criteria:

    None

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Montefiore Medical Center Bronx New York United States 10467

    Sponsors and Collaborators

    • Albert Einstein College of Medicine

    Investigators

    • Principal Investigator: Henny Billett, Albert Einstein College of Medicine

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Henny Billett, Chief, Division of Hematology, Albert Einstein College of Medicine
    ClinicalTrials.gov Identifier:
    NCT02442011
    Other Study ID Numbers:
    • 2013-2918
    First Posted:
    May 13, 2015
    Last Update Posted:
    Nov 16, 2021
    Last Verified:
    Nov 1, 2021
    Individual Participant Data (IPD) Sharing Statement:
    Yes
    Plan to Share IPD:
    Yes
    Keywords provided by Henny Billett, Chief, Division of Hematology, Albert Einstein College of Medicine
    Hematology Biobank
    Additional relevant MeSH terms:
    Hematologic Diseases

    Study Results

    No Results Posted as of Nov 16, 2021